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Typically, transfemoral access using the self-expanding CoreValve Revalving System is the
initial default strategy in patients undergoing transcatheter aortic valve implantation
(TAVI). Subclavian access is a potential alternative to the femoral route in patients with
peripheral vascular disease. The left subclavian is preferred due to the favourable
orientation of the delivery system through the aortic arch and annulus. However, right
subclavian access may also be feasible in cases with specific anatomical conditions of the
aortic root and valve annulus. We present a case where TAVI using the CoreValve
prosthesis was performed via right subclavian artery with good 1 year outcome.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Transcatheter aortic valve implantation (TAVI) is an alterna-
tive approach to surgical aortic valve replacement (SAVR) in
high-risk patients with severe symptomatic aortic stenosis.
Typically, transfemoral access using the self-expanding
CoreValve Revalving System (Medtronic Cardiovascular, Santa
Rosa, CA) is the initial default strategy. Subclavian access is a
potential alternative to the femoral route in patients with
peripheral vascular disease involving the iliac artery. The left
subclavian/axillary artery is preferred due to the favourable
orientation of the delivery system through the aortic arch and
annulus. However, right subclavian access may also be fea-
sible in cases with specific anatomical conditions of the aortic
root and valve annulus. Here, we present one of the threech Society of Cardiology.
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ek).cases where TAVI using the CoreValve prosthesis was per-
formed via right subclavian artery in our centre.2. Case report
A 60-year-old diabetic on insulin therapy and with a previous
history of a coronary artery bypass graft (LIMA-LAD) with
mitral valvuloplasty, after carotid end-arterectomy of both
carotid arteries and with peripheral artery disease and stent-
ing of both common iliac arteries, was hospitalised for con-
gestive heart failure several times over the previous year.
He was also treated for myelodysplastic syndrome with
pancytopoenia (haemoglobin (HGB) 80 g/L, platelets (PLT)
46 G/L, and white blood cells (WBC) 1.7 T/L). EchocardiographyPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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Fig. 1 – Computed tomography (CT) of the aortic arch. Ostium of the left subclavian artery (LSA) was 4 mm in diameter and
calcified with 50% stenosis. Ostium of the truncus brachiocephalicus (TB) with calcified plaque.
Fig. 2 – Carotid protective device placed in the right carotid
artery (arrow).
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of 4.8 m/s, and a pressure gradient (PG) of 90/48 mmHg. His
euroscore was 22% and he was indicated for TAVI by the Heart
Team. The diameter of the stented common iliac arteries was
5 mm on CT and in the ostium of the left subclavian artery a
calcified plaque with 50% stenosis was present with a residual
diameter of 4 mm. Calcified plaque was also present in the
ostium of the truncus brachiocephalicus (Fig. 1). We decided to
perform TAVI through a right subclavian access with a carotid
protective device inserted through the right femoral artery due
the high risk of calcified plaque embolisation (Fig. 2). TAVI was
performed under general anaesthesia after administration ofthree platelet separator units and two transfusions. The
right subclavian artery was exposed surgically. After balloon
valvuloplasty, a 29-mm CoreValve prosthesis was success-
fully implanted. The prosthesis was observed in an asym-
metric position during implantation, but the position has
completely normalised after complete release (Fig. 3). White
atherosclerotic masses were visible in the protective device
after its retrieval. No complications or conduction abnormal-
ities occurred and the patient was discharged after 8 days.
The patient underwent 1 year of echocardiographic and clinical
control, his NYHA status was I, and the aortic prosthesis
showed good function with mild aortic paravalvular leakage.3. Discussion
Since April 2009, TAVI using the CoreValve prosthesis has
been performed in 67 high-risk patients with severe sympto-
matic aortic stenosis in our centre. These cases included six
patients in whom subclavian access was used. The prosthesis
was successfully implanted in three patients via right sub-
clavian access with good 1 year outcome. In all three patients,
femoral and left subclavian access was not possible due to
calcification and tortuosity of the vessel with diameters less
than 6 mm.
To date, there have been only up to 10 cases reported in the
literature where right subclavian access was used during the
TAVI procedure [1–3]. Our three cases confirm the feasibility
and good mid-term clinical outcomes of right subclavian
access during TAVI if specific anatomical conditions are
present (angulation of the aortic valve annular plane less
than 301 from horizontal–vertical aorta) [4]. Based on the
presented case, the insertion of the carotid protective device
seems to be effective in prevention of periprocedural stroke if
atherosclerotic disease of the truncus brachiocephalicus is
present and right subclavian access is used. However, in the
case of ileofemoral disease, left subclavian access remains
the first choice [5] and right subclavian access should only be
Fig. 3 – Asymmetric position of the prosthesis during implantation (left) and final position normalisation after catheter
retrieval (right).
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osity or if there is a risk of LIMA obstruction or dissection in
patients with a previous functional coronary bypass graft.
This approach could be also preferred over more invasive
direct transaortic access.4. Conclusion
Right subclavian access in TAVI using the CoreValve prosthe-
sis is feasible in cases with specific anatomical conditions of
the aortic root and valve annulus if femoral and left sub-
clavian access is not suitable. Carotid protective device could
be considered for prevention of periprocedural stroke in
selected patients if this access is used.Disclosure
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